ANTIBIOTIC INJECTABLES Meropenem(FOR CRITICAL CARE)

Products

Information

Meropenem injectable formulations, developed under stringent International regulatory standards. Our flexible manufacturing capabilities allow us to cater to partner-specific requirements across global markets — whether for direct product supply or as a trusted third-party / contract manufacturing partner. Product Highlights: API Strengths Available: 500 mg, 1 g & 2 g Dosage Form: Sterile powder for injection (vial) Packing Options: Glass vials with flip-off seals and tear-off aluminum caps, available in single vial mono, combi packs(WFI) or 10's vials pack Customization: Product formulation, packaging, labeling, and documentation tailored to regulatory and commercial requirements of partner markets.Marketing support through literatures and Trainings for sales teams, CME presentations etc. could also be arranged. Shelf Life: 24 months (standard); stability studies available for custom specifications.

Product Categories

Finished Dosage Forms
- Injectables

Distribution Areas

OceaniaNorth America (USA, Canada)AfricaMiddle East Region (e.g. UAE)Central America (e.g. Mexico)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South America (e.g. Brazil, Colombia)South East Asia (e.g. Thailand, Philippines, Singapore)

Supplied From

GermanyIndia

Venus Remedies Ltd/Venus Pharma GmbHVenus Remedies Limited/Venus Pharma GmbH, globally recognized for their unwavering commitment to quality and innovation, is among the 10 leading fixed-dosage injectable manufacturers in the world. Having a commercial presence in 100+ countries with a portfolio of 75 products spread over Europe, Australia, Africa, Asia-Pacific, Commonwealth States, the Middle East, Latin America and the Caribbean region, the company has nine globally benchmarked facilities in Panchkula, Baddi and Werne (Germany), apart from 11 overseas marketing offices.

ANTIBIOTIC INJECTABLES Meropenem(FOR CRITICAL CARE)

Information

Log in